Article

Unveiling Prognostics Biomarkers of Tyrosine Metabolism Reprogramming in Liver Cancer by Cross-platform Gene Expression Analyses

2020-02-05

Abstract excerpt

Tyrosine is mainly degraded in the liver by a series of enzymatic reactions. Abnormal expression of the tyrosine catabolic enzyme tyrosine aminotransferase (TAT) has been reported in patients with hepatocellular carcinoma (HCC). Despite this, aberration in tyrosine metabolism has not been investigated in cancer development. In this work, we conduct comprehensive cross-platform study to obtain foundation for discov...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d019da43-0fa4-57b0-a055-e0b8b3603e73
DOI: 10.1101/2020.02.05.935429

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Unveiling Prognostics Biomarkers of Tyrosine Metabolism Reprogramming in Liver Cancer by Cross-platform Gene Expression AnalysesDOI 10.1101/2020.02.05.935429Read

Unveiling prognostics biomarkers of tyrosine metabolism reprogramming in liver cancer by cross-platform gene expression analyses.Semantic proximity Read

Identification and validation of a tyrosine metabolism-related prognostic prediction model and characterization of the tumor microenvironment infiltration in hepatocellular carcinomaSemantic proximity Read

Mongolian HCC vs. Caucasian HCC: The Metabolic Reprogramming Process in Mongolian HCC is an Interesting DifferenceSemantic proximity Read

Multi-omics Signatures and Translational Potential to Improve Thyroid Cancer Patient OutcomeSemantic proximity Read

Analysis for MBOAT Family Genes in Human Liver Hepatocellular CarcinomaSemantic proximity Read

Integrative multi-omics characterization of hepatocellular carcinoma in Hispanic patientsSemantic proximity Read

METTL1-driven nucleotide metabolism reprograms the immune microenvironment in hepatocellular carcinoma: a multi-omics approach for prognostic biomarker discoverySemantic proximity Read

Loss of alanine-glyoxylate and serine-pyruvate aminotransferase expression accelerated the progression of hepatocellular carcinoma and predicted poor prognosis.Semantic proximity Read

Integrated metabolic and genetic analysis reveals distinct features of primary differentiated thyroid cancer and its metastatic potential in humansSemantic proximity Read

Multi-OMICs and Genome Editing Perspectives on Liver Cancer Signaling Networks.Semantic proximity Read

mTOR/HDAC1 Crosstalk Mediated Suppression of ADH1A and ALDH2 Links Alcohol Metabolism to Hepatocellular Carcinoma Onset and Progression in silicoSemantic proximity Read

HEPATOCELLULAR CARCINOMA KINOME ATLAS AS AN EMPLOYABLE INSTRUMENTED PERSONALIZED MEDICINESemantic proximity Read